Loading insider details...
Beta
Latest Form 4 (Jul 10, 2026): Exercise/Conversion of 3,562 RLYB shares, $8.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Rallybio Corp (RLYB) | Exercise/Conversion | 3,562 | $8.5K |
| Jun 3, 2026 | Shattuck Labs, Inc. (STTK) | Grant/Award | 81,000 | n/a |
| Jul 16, 2025 | Shattuck Labs, Inc. (STTK) | Grant/Award | 33,150 | n/a |
| May 15, 2025 | Rallybio Corp (RLYB) | Grant/Award | 28,500 | n/a |
| Jun 21, 2024 | Shattuck Labs, Inc. (STTK) | Grant/Award | 27,700 | n/a |
| Jun 6, 2024 | Cara Therapeutics, Inc. (CARA) | Grant/Award | 150,647 | n/a |
| May 17, 2024 | Rallybio Corp (RLYB) | Grant/Award | 16,500 | n/a |
| May 16, 2024 | Premier, Inc. (PINC) | Sale | 6,629 | $131.6K |
| Aug 4, 2023 | Cara Therapeutics, Inc. (CARA) | Grant/Award | 155,747 | n/a |
| May 31, 2023 | Shattuck Labs, Inc. (STTK) | Grant/Award | 40,258 | n/a |